Reversible Thrombocytosis and Anemia Due to Miconazole Therapy

Miconazole was administered intravenously in six consecutive patients with, active coccidioidal infection. Such treatment was associated with progressive anemia and thrombocytosis. The hematological abnormalities appeared to be dose related and potentially reversible. Bone marrow studies demonstrated erythroid hypoplasia and increased or active platelet production in three subjects. No hemorrhagic or thrombotic episodes were identified. It is suggested that careful hematological monitoring be performed in subjects undergoing systemic miconazole therapy.

[1]  H. B. Levine Miconazole in Coccidioidomycosis , 1977, Proceedings of the Royal Society of Medicine.

[2]  D. Stevens,et al.  Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro. , 1975, The Journal of infectious diseases.

[3]  P. Klener,et al.  Possible mechanism of vinblastine-induced thrombocytosis. , 2009, Scandinavian journal of haematology.

[4]  E. Goldstein,et al.  Miconazole therapy for coccidioidomycosis. , 1974, JAMA.

[5]  T. M. Savege,et al.  Some cardiorespiratory effects of Cremophore EL in man. , 1973, British Journal of Anaesthesia.

[6]  J. Robertson,et al.  Vincristine-induced thrombocytosis studied with 75 Se selenomethionine. , 1972, Acta haematologica.

[7]  J. Robertson,et al.  The Effect of Vincristine on the Platelet Count in Rats , 1970, British journal of haematology.

[8]  J. Mitchell,et al.  Perwinkle alkaloids and platelets. , 1969, Lancet.

[9]  J. Robertson,et al.  Periwinkle alkaloids and the platelet-count. , 1969, Lancet.

[10]  F. Stohlman,et al.  ANEMIA INDUCED BY AMPHOTERICIN B. , 1964, JAMA.